ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Condition(s):T-cell Large Granular Lymphocytic LeukemiaLast Updated:December 6, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):T-cell Large Granular Lymphocytic LeukemiaLast Updated:December 6, 2023Recruiting
Condition(s):T-Cell Large Granular Lymphocyte LeukemiaLast Updated:February 1, 2024Recruiting
Condition(s):T-Cell Large Granular Lymphocyte LeukemiaLast Updated:January 31, 2024Recruiting
Condition(s):Non Hodgkin Lymphoma (NHL); Peripheral T-cell Lymphoma (PTCL); Cutaneous T-Cell Lymphoma (CTCL); Large Granular Lymphocytic Leukemia (LGL-L); T-cell Prolymphocytic Leukemia (T-PLL); Solid TumorsLast Updated:August 3, 2023Recruiting
Condition(s):LGLL – Large Granular Lymphocytic Leukemia; Primary Cutaneous T-Cell Lymphoma – Category; Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma; Hepatosplenic T-cell Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma; Aggressive NK Cell Leukemia; Systemic EBV1 T-cell Lymphoma, if CD8 Positive; Hydroa Vacciniforme-Like Lymphoproliferative Disorder; Extranodal NK/T Cell Lymphoma, Nasal Type; Enteropathy-Associated T-Cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Indolent Chronic Lymphoproliferative Disorder (CLPD) (CD8+ or NK Derived) of the GI Tract; Other CD8+/NK Cell Driven Lymphoma Not Listed AboveLast Updated:October 27, 2023Recruiting
Condition(s):Large Granular Lymphocyte LeukemiaLast Updated:January 25, 2024Recruiting
Condition(s):T-LGL Leukemia; Clpd-NkLast Updated:July 1, 2020Recruiting
Condition(s):Advanced Solid Tumor; Hematological MalignancyLast Updated:January 31, 2024Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:April 29, 2022Recruiting
Condition(s):T-cell Lymphoma; NK-Cell Lymphoma; T-cell Prolymphocytic Leukemia; T-cell Large Granular Lymphocytic Leukemia; Chronic Lymphoproliferative Disorder of NK Cells; Aggressive NK-cell Leukemia; Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder); Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood; Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form; Hydroa Vacciniforme-Like Lymphoproliferative Disorder; Adult T-cell Leukemia/Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Enteropathy-associated T-cell Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Intestinal T-Cell Lymphoma, Not Otherwise Specified; Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract; Hepatosplenic T-cell Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma; Primary Cutaneous T-cell Lymphoma; Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma; Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Follicular T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; Breast Implant-Associated Anaplastic Large Cell LymphomaLast Updated:December 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.